Benzinga | Dec 11, 2020 08:58AM EST

Akari Therapeutics Announces 'Transfusion independence of 79% reported for 14 formerly transfusion dependent PNH patients treated with nomacopan for at least six months'

Transfusion independence of 79% reported for 14 formerly transfusion dependent PNH patients treated with nomacopan for at least six months. This compares favorably to published data which reports that between 50% and 60% of transfusion dependent PNH patients treated with eculizumab therapy became transfusion independent.